Evidence map›Paper›PMID 34360236›Full record

SynthesisInternational journal of environmental research and public health2021

Gender-Dependent Specificities in Cutaneous Melanoma Predisposition, Risk Factors, Somatic Mutations, Prognostic and Predictive Factors: A Systematic Review.

Oriana D'Ecclesiis, Saverio Caini, Chiara Martinoli, Sara Raimondi, Camilla Gaiaschi, Giulio Tosti, Paola Queirolo, Camilla Veneri, Calogero Saieva, Sara Gandini and 1 more

Open access · goldAbstract readSystematic Review
In one paragraph

Synthesis in International journal of environmental research and public health, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.4field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. Comprehensive Genomic Profiles of Melanoma in Veterans Compared to Reference Databases.Federal practitioner : for the health care professionals of the VA, DoD, and PHS · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review: The Key Factors to Melanomagenesis.Life (Basel, Switzerland) · 2023
    Review
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 2 countries.

Oriana D'EcclesiisDepartment of Experimental Oncology, IEO-European Institute of Oncology IRCCS, 20139 Milan, Italy.
Saverio CainiCancer Risk Factors and Lifestyle Epidemiology Unit, Institute for Cancer Research, Prevention and Clinical Network (ISPRO), Via Cosimo il Vecchio 2, 50139 Florence, Italy.ORCID 0000-0002-2262-1102
Chiara MartinoliDepartment of Experimental Oncology, IEO-European Institute of Oncology IRCCS, 20139 Milan, Italy.
Sara RaimondiDepartment of Experimental Oncology, IEO-European Institute of Oncology IRCCS, 20139 Milan, Italy.
Camilla GaiaschiGENDERS Center, Department of Social and Political Sciences, Università degli Studi di Milano, 20122 Milan, Italy.ORCID 0000-0003-3768-9529
Giulio TostiDivision of Melanoma Surgery, Sarcoma and Rare Tumors, IEO-European Institute of Oncology IRCCS, 20139 Milan, Italy.ORCID 0000-0001-8231-2814
Paola QueiroloDivision of Melanoma Surgery, Sarcoma and Rare Tumors, IEO-European Institute of Oncology IRCCS, 20139 Milan, Italy.
Camilla VeneriGENDERS Center, Department of Social and Political Sciences, Università degli Studi di Milano, 20122 Milan, Italy.
Calogero SaievaCancer Risk Factors and Lifestyle Epidemiology Unit, Institute for Cancer Research, Prevention and Clinical Network (ISPRO), Via Cosimo il Vecchio 2, 50139 Florence, Italy.ORCID 0000-0002-0117-1608
Sara GandiniDepartment of Experimental Oncology, IEO-European Institute of Oncology IRCCS, 20139 Milan, Italy.ORCID 0000-0002-1348-4548
Susanna ChioccaDepartment of Experimental Oncology, IEO-European Institute of Oncology IRCCS, 20139 Milan, Italy.ORCID 0000-0002-9721-0850
European Institute of Oncology · ITUniversity of Milan · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND AND

aimOver the last decades, the incidence of melanoma has been steadily growing, with 4.2% of the population worldwide affected by cutaneous melanoma (CM) in 2020 and with a higher incidence and mortality in men than in women. We investigated both the risk factors for CM development and the prognostic and predictive factors for survival, stratifying for both sex and gender.

methodsWe conducted a systematic review of studies indexed in PUB-MED, EMBASE, and Scopus until 4 February 2021. We included reviews, meta-analyses, and pooled analyses investigating differences between women and men in CM risk factors and in prognostic and predictive factors for CM survival. DATA SYNTHESIS: Twenty-four studies were included, and relevant data extracted. Of these, 13 studies concerned potential risk factors, six concerned predictive factors, and five addressed prognostic factors of melanoma. DISCUSSION: The systematic review revealed no significant differences in genetic predisposition to CM between males and females, while there appear to be several gender disparities regarding CM risk factors, partly attributable to different lifestyles and behavioral habits between men and women. There is currently no clear evidence of whether the mutational landscapes of CM differ by sex/gender. Prognosis is justified by a complex combination of phenotypes and immune functions, while reported differences between genders in predicting the effectiveness of new treatments are inconsistent. Overall, the results emerging from the literature reveal the importance of considering the sex/gender variable in all studies and pave the way for including it towards precision medicine.

conclusionsMen and women differ genetically, biologically, and by social construct. Our systematic review shows that, although fundamental, the variable sex/gender is not among the ones collected and analyzed.

Indexed as

MelanomaSkin NeoplasmsFemaleHumansMaleMutationPrognosisRisk FactorsSex Factorsgendermelanomameta-analysisprecision medicinepredictive factorsprognostic factorsrisk factorssexsystematic review

Identifiers

PMID34360236
PMCPMC8345480
OpenAlexW3183230557

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.